These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23761833)

  • 21. Recurrent infantile inflammatory myofibroblastic tumor of mesentery--Case report and review of imaging findings.
    Gupta A; Sharma S; Mittal A; Barwad A; Rastogi S
    Radiol Case Rep; 2021 Mar; 16(3):504-510. PubMed ID: 33363692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of recurrent pediatric inflammatory myofibroblastic tumor in a single patient with a novel chemotherapeutic regimen containing celecoxib.
    Johnson K; Notrica DM; Carpentieri D; Jaroszewski D; Henry MM
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):414-6. PubMed ID: 23669730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Casanova M; Brennan B; Alaggio R; Kelsey A; Orbach D; van Noesel MM; Corradini N; Minard-Colin V; Zanetti I; Bisogno G; Gallego S; Merks JHM; De Salvo GL; Ferrari A
    Eur J Cancer; 2020 Mar; 127():123-129. PubMed ID: 32007712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic Anaplastic Lymphoma Kinase-1 (ALK-1)-Rearranged Inflammatory Myofibroblastic Sarcoma to the Brain with Leptomeningeal Involvement: Favorable Response to Serial ALK Inhibitors: A Case Report.
    Yuan C; Ma MJ; Parker JV; Mekhail TM
    Am J Case Rep; 2017 Jul; 18():799-804. PubMed ID: 28713152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraosseous inflammatory myofibroblastic tumor of the mandible with a novel ATIC-ALK fusion mutation: a case report.
    Tateishi Y; Okudela K; Kawai S; Suzuki T; Umeda S; Matsumura M; Kioi M; Ohashi K
    Diagn Pathol; 2016 Nov; 11(1):132. PubMed ID: 27846861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anaplastic lymphoma kinase-directed therapy in inflammatory myofibroblastic tumors.
    Tothova Z; Wagner AJ
    Curr Opin Oncol; 2012 Jul; 24(4):409-13. PubMed ID: 22664824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric Inflammatory Myofibroblastic Tumors of the Airway: Two Case Reports with Varying Clinical Presentation.
    Kumar N; Saravanamuthu T; Srinivasan A; Raman T; Scott JX
    Iran J Otorhinolaryngol; 2018 May; 30(98):171-176. PubMed ID: 29876333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: A potential diagnostic pitfall.
    Yorita K; Togashi Y; Nakagawa H; Miyazaki K; Sakata S; Baba S; Takeuchi K; Hayashi Y; Murakami I; Kuroda N; Oda Y; Kohashi K; Yamada Y; Kiyozawa D; Michal M; Michal M
    Pathol Int; 2019 Jun; 69(6):366-371. PubMed ID: 31215130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Remission of ALK-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: A case report and review of the literature.
    Watanabe H; Uruma T; Tazaki G; Tajiri T; Kikuchi R; Itoh M; Aoshiba K; Nakamura H
    Oncol Lett; 2016 Mar; 11(3):1757-1761. PubMed ID: 26998073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation.
    Siminovich M; Galluzzo L; López J; Lubieniecki F; de Dávila MT
    Pediatr Dev Pathol; 2012; 15(3):179-86. PubMed ID: 22280150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
    Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
    Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Inflammatory myofibroblastic tumour'-like dedifferentiation of anaplastic lymphoma kinase-rearranged lung adenocarcinoma.
    Mason EF; Fletcher CD; Sholl LM
    Histopathology; 2016 Sep; 69(3):510-5. PubMed ID: 26880345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
    Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
    J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracranial remission with brigatinib rechallenge as fifth-line ALK inhibition therapy in a lung cancer patient.
    Hochmair M; Weinlinger C; Prosch H
    Anticancer Drugs; 2019 Nov; 30(10):1058-1060. PubMed ID: 31033499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
    Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
    Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete and Repeated Response of a Metastatic ALK-rearranged Inflammatory Myofibroblastic Tumor to Crizotinib in a Teenage Girl.
    Gaudichon J; Jeanne-Pasquier C; Deparis M; Veyssière A; Heyndrickx M; Minckes O; Orbach D
    J Pediatr Hematol Oncol; 2016 May; 38(4):308-11. PubMed ID: 26808369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.
    Baldi GG; Brahmi M; Lo Vullo S; Cojocaru E; Mir O; Casanova M; Vincenzi B; De Pas TM; Grignani G; Pantaleo MA; Blay JY; Jones RL; Le Cesne A; Frezza AM; Gronchi A; Collini P; Dei Tos AP; Morosi C; Mariani L; Casali PG; Stacchiotti S
    Oncologist; 2020 Nov; 25(11):e1777-e1784. PubMed ID: 32584482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory myofibroblastic tumor in the head and neck-a neoplasm with both tumor features and inflammation.
    Zhang Y; Peng C; Tian Z; Cao W; Yang X; Ji T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Nov; 130(5):e316-e323. PubMed ID: 32414698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib.
    Mansfield AS; Murphy SJ; Harris FR; Robinson SI; Marks RS; Johnson SH; Smadbeck JB; Halling GC; Yi ES; Wigle D; Vasmatzis G; Jen J
    Ann Oncol; 2016 Nov; 27(11):2111-2117. PubMed ID: 27742657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.